Literature DB >> 11243377

C/EBPepsilon -/- mice: increased rate of myeloid proliferation and apoptosis.

W Verbeek1, M Wächter, J Lekstrom-Himes, H P Koeffler.   

Abstract

CCAAT/enhancer binding protein epsilon (C/EBPepsilon) is essential for terminal granulocytic differentiation. Its expression begins at the transition between the proliferative and non-proliferative compartments of myelopoiesis. We studied the effect of targeted disruption of the C/EBPepsilon gene on murine myeloid proliferation and apoptosis. Bone marrow cellularity of C/EBPepsilon -/- and wild-type mice was 95% and 65%, respectively. The C/EBPepsilon -/- mice had an expansion in the number of their CFU-GM/femur. The number of myeloid committed progenitor cells in the peripheral blood and the spleen of these mice was also increased. Bromodeoxyuridine (BrDU) pulse labeling studies demonstrated that the fraction of actively proliferating cells was two-fold higher in the bone marrow of C/EBPepsilon -/- mice. However, the number of myeloid colonies arising from purified Sca-1+/lin- early hematopoietic progenitor cells and from bone marrow mononuclear cells grown in different cytokine combinations was not significantly different between wild-type and knock-out mice. Also, long-term marrow growth, and CFU were not different between the wild-type and C/EBPepsilon -/- mice. The sensitivity to induction of apoptosis in the committed progenitor cell compartment after either withdrawal of growth factor or brief exposure to etoposide was normal. However, Gr-1 antigen-positive C/EBPepsilon -/- granulocytic cells showed an increased rate of apoptosis in comparison to their wild-type counterparts. In summary, the myeloid compartment appears to be expanded in mice lacking C/EBPepsilon. However, this is not the consequence of an intrinsic myeloproliferation but due to an indirect, possibly cytokine-mediated stimulation of myelopoiesis in vivo. C/EBPepsilon may have a role in the inhibition of apoptosis in maturing granulocytic cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243377     DOI: 10.1038/sj.leu.2401995

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  9 in total

Review 1.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

2.  Chromatin-remodeling factor SMARCD2 regulates transcriptional networks controlling differentiation of neutrophil granulocytes.

Authors:  Maximilian Witzel; Daniel Petersheim; Yanxin Fan; Ehsan Bahrami; Tomas Racek; Meino Rohlfs; Jacek Puchałka; Christian Mertes; Julien Gagneur; Christoph Ziegenhain; Wolfgang Enard; Asbjørg Stray-Pedersen; Peter D Arkwright; Miguel R Abboud; Vahid Pazhakh; Graham J Lieschke; Peter M Krawitz; Maik Dahlhoff; Marlon R Schneider; Eckhard Wolf; Hans-Peter Horny; Heinrich Schmidt; Alejandro A Schäffer; Christoph Klein
Journal:  Nat Genet       Date:  2017-04-03       Impact factor: 38.330

3.  In vivo deficiency of both C/EBPβ and C/EBPε results in highly defective myeloid differentiation and lack of cytokine response.

Authors:  Tadayuki Akagi; Nils H Thoennissen; Ann George; Gay Crooks; Jee Hoon Song; Ryoko Okamoto; Daniel Nowak; Adrian F Gombart; H Phillip Koeffler
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

4.  The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils.

Authors:  Tatiana V Cohen; Kimberly D Klarmann; Krisada Sakchaisri; Jason P Cooper; Douglas Kuhns; Miriam Anver; Peter F Johnson; Simon C Williams; Jonathan R Keller; Colin L Stewart
Journal:  Hum Mol Genet       Date:  2008-07-11       Impact factor: 6.150

5.  Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.

Authors:  Richa Bedi; Jian Du; Arun K Sharma; Ignatius Gomes; Steven J Ackerman
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

6.  Human α-defensin expression is not dependent on CCAAT/enhancer binding protein-ε in a murine model.

Authors:  Andreas Glenthøj; Sara Dahl; Maria T Larsen; Jack B Cowland; Niels Borregaard
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

7.  A crucial role for the ubiquitously expressed transcription factor Sp1 at early stages of hematopoietic specification.

Authors:  Jane Gilmour; Salam A Assi; Ulrike Jaegle; Divine Kulu; Harmen van de Werken; Deborah Clarke; David R Westhead; Sjaak Philipsen; Constanze Bonifer
Journal:  Development       Date:  2014-05-21       Impact factor: 6.868

8.  C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.

Authors:  Sanjay Anand; John Ebner; Christine B Warren; Manu S Raam; Melissa Piliang; Steven D Billings; Edward V Maytin
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

9.  CCAAT/Enhancer-Binding Protein ε27 Antagonism of GATA-1 Transcriptional Activity in the Eosinophil Is Mediated by a Unique N-Terminal Repression Domain, Is Independent of Sumoylation and Does Not Require DNA Binding.

Authors:  Monika J Stankiewicz; Jian Du; Dominick Martinico; Steven J Ackerman
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.